Ilivia Neo 7 VR-T DX 429530; Intica Neo 7 VR-T DX 429559; Intica Neo 5 VR-T DX 429569
Biotronik, Inc. · Decision date Oct 16, 2025
What did the FDA decide?
FDA records P980023/S139 as a supplement to PMA P980023, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 16, 2025.
FDA approval order statement
introducing an alternative supplier for a set screw component
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 16, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P980023/S139
- Regulatory pathway
- PMA supplement
- Applicant
- Biotronik, Inc.
- Product code
- LWS
- Decision code
- OK30
- Decision date
- Oct 16, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implantable cardioverter defibrillator (non-CRT).
- Applicant
- Biotronik, Inc.
- Product code
- LWS
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P980023. Subsequent supplements may change the device or its indications.
FDA decision timeline
P980023 · Original PMA
PHYLAX IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SYSTEM
P980023/S137 · Related supplement
Ilivia Neo 7 VR-T DX; Ilivia Neo 7 VR-T; Intica Neo 7 VR-T DX; Intica Neo 7 VR-T; Intica Neo 5 VR-T DX; Intica Neo 5 VR-
P980023/S139 received
Application receipt date recorded by FDA.
P980023/S138 · Related supplement
Ilivia Neo 7 VR-T DX; Ilivia Neo 7 VR-T; Intica Neo 7 VR-T DX; Intica Neo 7 VR-T; Intica Neo 5 VR-T DX; Intica Neo 5 VR-
P980023/S139 · FDA decision
30-Day Notice
P980023/S141 · Related supplement
Pamira S 60 428768 Pamira S 65 428769 Pamira S 75 428770 Pamira SD 60/16 428771 Pamira SD 65/16 428772 Pamira SD 65/18 4
P980023/S136 · Related supplement
Acticor Sky VR-T 481989, Rivacor Sky VR-T 481984, Rivacor Rise VR-T 482020, Rivacor Aura VR-T 482015, Acticor Sky VR-T D
P980023/S143 · Related supplement
PHYLAX IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SYSTEM
P980023/S142 · Related supplement
PHYLAX IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SYSTEM
P980023/S144 · Related supplement
Acticor Sky VR-T (481989); Rivacor Sky VR-T (481984); Rivacor Rise VR-T (482020); Rivacor Aura VR-T (482015); Acticor Sk
P980023/S145 · Related supplement
Acticor Sky VR-T, Rivacor Sky VR-T, Rivacor Rise VR-T, Rivacor Aura VR-T, Acticor Sky VR-T DX, Rivacor Sky VR-T DX, Riva
P980023/S147 · Related supplement
Acticor Sky VR-T (481989); Rivacor Sky VR-T (481984); Rivacor Rise VR-T (482020); Rivacor Aura VR-T (482015); Acticor Sk
P980023/S148 · Related supplement
Plexa ProMRI S 60, Plexa ProMRI S 65, Plexa ProMRI S 75, Plexa ProMRI SD 60/16, Plexa ProMRI SD 65/16, Plexa ProMRI SD 6
P980023/S150 · Related supplement
Pamira S 60; Pamira S 65; Pamira S 75; Pamira SD 60/16; Pamira SD 65/16; Pamira SD 65/18; Pamira SD 75/18; Pamira S DX 6
P980023/S146 · Related supplement
Acticor Sky VR-T, Rivacor Sky VR-T, Rivacor Rise VR-T, Rivacor Aura VR-T, Acticor Sky VR-T DX, Rivacor Sky VR-T DX, Riva
P980023/S140 · Related supplement
Ilivia Neo 7 VR-T DX 429530; Intica Neo 7 VR-T DX 429559; Intica Neo 5 VR-T DX 429569
P980023/S151 · Related supplement
Acticor Sky VR-T, Rivacor Sky VR-T, Rivacor Rise VR-T, Rivacor Aura VR-T, Acticor Sky VR-T DX, Rivacor Sky VR-T DX, Riva
P980023/S149 · Related supplement
Acticor Sky VR-T 481989; Rivacor Sky VR-T 481984; Rivacor Rise VR-T 482020; Rivacor Aura VR-T 482015; Acticor Sky VR-T D
P980023/S152 · Related supplement
Ilivia Neo 7 VR-T DX DF-1 ProMRI, Ilivia Neo 7 VR-T DF-1 ProMRI, Intica Neo 7 VR-T DX DF-1 ProMRI, Intica Neo 7 VR-T DF-
P980023/S153 · Related supplement
Ilivia Neo 7 VRT DX, Intica Neo 7 VRT DX, Intica Neo 5 VRT DX, Acticor Sky VR-T, Rivacor Sky VR-T, Rivacor Rise VR-T, Ri
Timeline entries are records held by MedtechLedger for P980023. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P980023
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biotronik, Inc. | PMA approval | Oct 27, 1998 | FDA | |
| Biotronik, Inc. | PMA supplement | Sep 15, 2025 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 1, 2025 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 29, 2025 | FDA | |
| Biotronik, Inc. | PMA supplement | Dec 18, 2025 | FDA | |
| Biotronik, Inc. | PMA supplement | Feb 3, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Feb 11, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Mar 5, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | May 7, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Jun 24, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Jul 1, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Sep 10, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Sep 17, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Sep 25, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Sep 25, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 9, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 13, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 22, 2026 | FDA |
Explore the linked device profile
Other records with product code LWS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Nov 5, 2026 | FDA | |
| Medtronic Cardiac Rhythm Disease Management | PMA supplement | Nov 4, 2026 | FDA | |
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICDP980016/S967 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 29, 2026 | FDA |
| Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 5, 2026 | FDA | |
| BOSTON SCIENTIFIC CORPORATION | PMA supplement | Oct 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Biotronik, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 6024 Jean Rd., Lake Oswego, OR, 97035
Sources and methodology
- Original FDA record: P980023/S139
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






